info@mediapharma.it
The company is focused on the discovery, development and commercialization of monoclonal antibodies
Receptor tyrosine kinase
Matricellular protein ligand
Cell surface component
MediaPharma on TG3 Abruzzo "Il Settimanale", October 29, 2011
RAI TG Leonardo interviews Prof. S. Iacobelli, Founder and President of MediaPharma
MediaPharma s.r.l. P.IVA.: IT 02282760699 | Rea di Chieti: 166532 The information provided on www.mediapharma.it is designed to complement, not replace, the relationship between a patient and his/her own physician.